Stay updated on MM-141 Combo in Front-line Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the MM-141 Combo in Front-line Pancreatic Cancer Clinical Trial page.

Latest updates to the MM-141 Combo in Front-line Pancreatic Cancer Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check23 days agoChange DetectedThe page has removed a citation for a study on istiratumab in metastatic pancreatic cancer, which may affect the credibility and comprehensiveness of the content related to this treatment.SummaryDifference0.4%
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check59 days agoChange DetectedThe page has undergone significant content removal regarding a clinical study on MM-141 for pancreatic cancer, including detailed descriptions of the study's purpose, methodology, and eligibility criteria. Additionally, the version number has been updated from v2.14.4 to v2.15.0.SummaryDifference11%
Stay in the know with updates to MM-141 Combo in Front-line Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MM-141 Combo in Front-line Pancreatic Cancer Clinical Trial page.